CDC researchers found that vaccination with a bivalent messenger RNA booster was effective against the XBB.1.5 subvariant of SARS-CoV-2.The relative effectiveness of the bivalent booster against symptomatic infection related to XBB or XBB.1.5 was 49%, 40%, an…